Skip to main content
CDC Website

Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional)

The purpose of this Funding Opportunity Announcement (FOA) is to encourage pilot and/or feasibility research in the following areas: 1) the development and pilot testing of new or adapted interventions to prevent or delay the initiation of substance use and/or the progression from use to misuse or disorder and 2) pre-trial feasibility and acceptability testing of services and service system research relevant to the prevention of substance use. In addition to the prevention of substance use, misuse and disorder, other outcomes of interest for the research supported through FOA include a reduction in negative sequalae such as deaths related to impaired driving, suicidal behavior (e.g., nonfatal and fatal attempts), and drug- or alcohol-related acquisition or transmission of HIV infection and viral hepatitis among diverse populations and settings.

Funding Organization:
The US Department of Health and Human Services National Institutes of Health
Funding Category:
Other Health-Related
Viral Hepatitis
Support Types:
Discretionary Grants
Fund ID:
Application Due Date:
Health Care Planning
Health Care Programs/Services
Hepatitis Prevention
HIV and AIDS Prevention
Technical Assistance
At Risk Persons
Community Based Organizations
Health Professionals
Health Services Organizations
People who inject drugs
People with substance use disorder
Persons with Hepatitis
Persons with HIV/AIDS
Last Updated:
Application Contact
Finacial/Grants Manager, NIDA
301-827- 4457
Technical Contact
Grant Contact